von Willebrand factor activation, granzyme-B and thrombocytopenia in meningococcal disease

M J Hollestelle1, T Sprong, N Bovenschen

  • 1Department of Clinical Chemistry and Haematology, University Medical Centre Utrecht, Utrecht, the Netherlands. J.Hollestelle@umcutrecht.nl

Abstract

Insights

Severe thrombocytopenia in meningococcal disease is linked to poor outcomes. This study reveals that von Willebrand factor (VWF) consumption, potentially due to granzyme B, drives thrombocytopenia during shock in this condition.

Area of Science:

  • Hematology
  • Infectious Diseases
  • Pediatrics

Background:

  • Severe thrombocytopenia is a poor prognostic indicator in invasive meningococcal disease.
  • Understanding the mechanisms of thrombocytopenia is crucial for improving patient outcomes.

Purpose of the Study:

  • To investigate the role of von Willebrand factor (VWF) in the development of thrombocytopenia during meningococcal disease.
  • To elucidate the pathophysiological mechanisms linking VWF to meningococcal-associated thrombocytopenia.

Main Methods:

  • Studied 32 children with severe meningococcal disease.
  • Measured VWF and related parameters, correlating them with shock and thrombocytopenia.
  • Conducted in vitro experiments to assess the effect of granzyme B (GrB) on VWF.

Main Results:

  • All patients exhibited elevated levels of active VWF and VWF propeptide upon admission.
  • Highest VWF propeptide levels indicated acute endothelial activation, particularly in patients with shock.
  • Active VWF levels were lower in patients with thrombocytopenia, suggesting VWF consumption, possibly aided by GrB, which was elevated in shock patients.

Conclusions:

  • VWF consumption, originating from endothelial cells, is a primary factor in the development of thrombocytopenia during meningococcal shock.
  • Granzyme B may play a role in VWF cleavage, contributing to thrombocytopenia.

Related Concept Videos

Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Determinants of Bacterial Pathogenicity and Virulence01:20

Determinants of Bacterial Pathogenicity and Virulence

Pathogenic bacteria employ a variety of strategies to establish infections, including the secretion of extracellular enzymes that act as potent virulence factors. These enzymes facilitate bacterial colonization of host tissues and help evade immune surveillance. By targeting structural components of host tissues and interfering with immune mechanisms, these enzymes play a pivotal role in disease progression.Extracellular Enzymes Facilitating Tissue Invasion: Several bacterial pathogens secrete...